Hints and tips:
Related Special Reports
...Analysts said the vote to oust Thompson reflected shareholders’ desire for Illumina to expedite the legal process around the Grail acquisition and divest the company....
...JPMorgan Chase chief executive Jamie Dimon yesterday shuffled his leadership team and consolidated some of the bank’s businesses as he grooms potential candidates for an eventual take over from him....
...After visiting Bahrain, where the US Navy’s Fifth Fleet is stationed, the defence secretary will stop aboard the USS Gerald R Ford aircraft carrier, currently in the eastern Mediterranean, and also travel...
...Illumina’s former chair John Thompson was ousted from its board in May following a proxy battle with Icahn, who criticised management for closing the $8bn acquisition of cancer test company Grail without...
...VMLY&R to create the world’s largest creative advertising company in October last year....
...Illumina’s former chair John Thompson was ousted from its board in May following a battle with Icahn, who criticised management for closing the $8bn acquisition of cancer test company Grail without regulatory...
...This followed the ousting of chairman John Thompson in a shareholder vote in May....
...“But it has been a polarising debate, given the potential impact of reforms on R&D budgets and what that means for global innovation.”...
...Instead, it has prioritised internal R&D and smaller acquisitions to add to its drug pipeline....
...The tech giant’s intent to buy the James R Thompson Center building, designed by Germany-born architect Helmut Jahn, from the state of Illinois came as the Chicago business community takes on a momentous...
...Thompson, a former chair and now a director at Microsoft, looks increasingly vulnerable ahead of the annual meeting....
...The resignation of deSouza, who was appointed chief executive in 2016, follows the departure last month of Illumina chair John Thompson, who was ousted in a shareholder vote following a proxy campaign by...
...Ireland-based life science companies have tripled R&D spending, as they undertake higher value activities including manufacturing of complex biologic medicines....
...Illumina shareholders have voted to oust company chair John Thompson and approve a nominee supported by Carl Icahn following a bruising proxy battle led by the veteran activist investor....
...Thompson was chief executive of Symantec at the time of its February 2006 acquisition of IMlogic, a company founded and led by deSouza....
...It’s also worth remembering Harvard MBA grads range from disgraced Enron boss, Jeffrey Skilling, to Wall Street superstar, Jamie Dimon....
...“These maps, they are intended to whet the appetite of both government and companies with adequate resources to be able to start down that R&D pathway,” said Terra Rogers, director of superhot rock energy...
...Influential proxy advisers Glass Lewis have recommended investors withhold their support for the reappointment of Illumina chief executive Francis deSouza and chair John Thompson to the board of the company...
...So we span the entire pharmaceutical R&D lifecycle.”...
...The world’s biggest genome sequencing company said on Thursday that Icahn’s nominees could not replace the “unique strength and experience” that Illumina’s chair John Thompson, chief executive Francis deSouza...
...Last year emerging biopharma companies were responsible for a record 65 per cent of the molecules in the R&D pipeline without a larger company involved, up from less than 50 per cent in 2016 and 34 per cent...
...Energy Source is written and edited by Tom Wilson, Jamie Smyth, Myles McCormick and Amanda Chu, with support from the FT’s global team of reporters....
...Icahn told the Financial Times deSouza and Thompson’s record in running Illumina was “very troubling” and it was time for both men to be replaced....
...That’s just how chief executive Jamie Dimon likes it. Everyone is replaceable (except for him). It is becoming more and more common to find star dealmakers outside of Wall Street’s biggest banks....
...Francis deSouza, Illumina chief executive, and chair John Thompson were talking to Icahn over his board nominees, the company said....
International Edition